SSA
ARRY

Schonfeld Strategic Advisors’s Array Biopharma Inc ARRY Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-28,900
Closed -$1.34M – 1362
2019
Q2 		$1.34M Sell
28,900
-657,200
-96% -$18.5M 0.05% 376
2019
Q1 		$16.7M Buy
686,100
+245,300
+56% +$5.11M 0.58% 27
2018
Q4 		$6.28M Sell
440,800
-90,900
-17% -$1.38M 0.24% 106
2018
Q3 		$8.08M Buy
531,700
+232,200
+78% +$3.56M 0.36% 64
2018
Q2 		$5.03M Buy
299,500
+174,188
+139% +$2.77M 0.27% 116
2018
Q1 		$2.04M Buy
125,312
+115,257
+1,146% +$1.85M 0.15% 196
2017
Q4 		$129K Buy
+10,055
New +$114K 0.01% 692
2016
Q4 		– Sell
-121,309
Closed -$819K – 693
2016
Q3 		$819K Buy
+121,309
New +$469K 0.14% 205

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Schonfeld Strategic Advisors's ARRY Position: Q3 2019 in Review

Schonfeld Strategic Advisors sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 28,900 shares — an estimated $1.34M sold.

Schonfeld Strategic Advisors first reported a position in ARRY in Q3 2016 and held it in 8 quarters. The position peaked at $16.7M in Q1 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Schonfeld Strategic Advisors reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 28,900 Array Biopharma Inc shares in Q3 2019, an estimated $1.34M.
  • Schonfeld Strategic Advisors first reported a position in Array Biopharma Inc in Q3 2016 and held it in 8 quarters.
  • Schonfeld Strategic Advisors's Array Biopharma Inc position peaked at $16.7M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.